Disclosure Plus

RedcapTour Co., Ltd. Decides on a Cash Dividend of 300 Won per Share

KIM YOON-JEONG
2026-07-02 14:22:53
[Edaily Reporter KIM YOON-JEONG ] RedcapTour Co., Ltd.(038390)announced on the 2nd that it has decided to pay a quarterly cash dividend of 300 won per common share.
The total dividend amount is 5,016,246,600 won, and the dividend yield is 3.1%.
The ex-dividend date is the 20th of this month.

Economy

Corporation

IT·Science

Economy

Lotte Construction: Cash Outflow Persists Despite Profit Rebound… Limits of the 700 Billion “Capital Illusion”

“Credit Checkpoint” is a section that assesses the credit rating risks of companies preparing to issue corporate bonds by examining their financial structure and cash flow. We evaluate a company’s sho…
2026-08-18 18:31:04
OLED TV Market Grows 20%… Samsung and TCL Lock Horns in the LCD TV Market
2026-08-18 17:02:41
[Exclusive] Could the Right to Operate Public Sports Facilities Under a Commissioned Management Model Emerge as a New Business Opportunity?
2026-08-18 16:43:03

Corporation

HEM Pharma Inc. Raises 54 Billion Won to Build New Sejong Plant No. 2... “Setting Sights on Global Markets, Including the U.S.”

#HEM Pharma Inc., a company specializing in microbiome healthcare, is accelerating the establishment of a key production hub targeting advanced global markets, including the U.S., after raising substa…
2026-08-18 17:40:03
'A First for K-Beauty': Chosun Beauty Enters Australian Supermarkets… Mamonde Expands into India
2026-08-18 17:19:55
From ‘Miwon’ to Pharmaceutical Ingredients… Daesang Accelerates Shift to High-Value-Added Materials Business
2026-08-18 16:50:47

IT·Science

National AI Team Fails at ‘Point Allocation Design’… The Paradox of AAII’s No. 1 Motif Being Eliminated [Kim Hyun-ah’s “Reading the IT World”]

My first thought upon seeing the results of the second evaluation of the “Dokpa-mo” (Proprietary AI Foundation Model) was, “Is this really right?”This is because Motif Technologies—which had ranked fi…
2026-08-18 16:44:45
ILDONG PHARM Group’s AIMS Establishes Support System for New Antimicrobial Drug Development… Resolving Development Bottlenecks
2026-08-18 16:34:02
[Exclusive] Second Round of Dokpamo: Upstage, SKT, and LG Corp.… Reasons for Motif’s Elimination from AAII Top Spot
2026-08-18 16:10:49